The closing price of Gossamer Bio Inc (NASDAQ: GOSS) was $1.38 for the day, down -0.72% from the previous closing price of $1.39. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 1073314 shares were traded.
Ratios:
Our analysis of GOSS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.94 and its Current Ratio is at 5.94. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on July 27, 2023, Downgraded its rating to Neutral and sets its target price to $1.25 from $8 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 15 ’23 when Milligan Sandra bought 32,000 shares for $0.79 per share. The transaction valued at 25,213 led to the insider holds 32,000 shares of the business.
Giraudo Bryan bought 200,000 shares of GOSS for $112,880 on Nov 13 ’23. The COO/CFO now owns 380,010 shares after completing the transaction at $0.56 per share. On Jun 22 ’23, another insider, Aranda Richard, who serves as the Chief Medical Officer of the company, sold 1,814 shares for $1.29 each. As a result, the insider received 2,340 and left with 197,574 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 315.82M and an Enterprise Value of 231.85M.
Stock Price History:
Over the past 52 weeks, GOSS has reached a high of $1.88, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.0222, while the 200-Day Moving Average is calculated to be 1.0115.
Shares Statistics:
GOSS traded an average of 1.20M shares per day over the past three months and 1.39M shares per day over the past ten days. A total of 225.41M shares are outstanding, with a floating share count of 188.82M. Insiders hold about 16.30% of the company’s shares, while institutions hold 79.44% stake in the company. Shares short for GOSS as of Feb 15, 2024 were 15.3M with a Short Ratio of 12.71, compared to 17.35M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.79% and a Short% of Float of 7.98%.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.23, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.6 and -$0.94 for the fiscal current year, implying an average EPS of -$0.77. EPS for the following year is -$0.7, with 9 analysts recommending between -$0.46 and -$1.
